New Zealand markets closed
  • NZX 50

    12,348.00
    -149.10 (-1.19%)
     
  • NZD/USD

    0.6713
    -0.0047 (-0.70%)
     
  • NZD/EUR

    0.5911
    -0.0058 (-0.97%)
     
  • ALL ORDS

    7,490.10
    -178.80 (-2.33%)
     
  • ASX 200

    7,175.80
    -166.60 (-2.27%)
     
  • OIL

    86.29
    -0.61 (-0.70%)
     
  • GOLD

    1,836.10
    -6.50 (-0.35%)
     
  • NASDAQ

    14,438.40
    -408.06 (-2.75%)
     
  • FTSE

    7,494.13
    -90.88 (-1.20%)
     
  • Dow Jones

    34,265.37
    -450.02 (-1.30%)
     
  • DAX

    15,603.88
    -308.45 (-1.94%)
     
  • Hang Seng

    24,965.55
    +13.20 (+0.05%)
     
  • NIKKEI 225

    27,522.26
    -250.67 (-0.90%)
     
  • NZD/JPY

    76.2790
    -0.7870 (-1.02%)
     

Insights on the Peripheral Arterial Disease Therapeutics Global Market to 2027 - Featuring AstraZeneca, Sanofi and TheraVasc Among Others - ResearchAndMarkets.com

·2-min read

DUBLIN, December 07, 2021--(BUSINESS WIRE)--The "Peripheral Arterial Disease (PAD) Therapeutics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for Peripheral Arterial Disease (PAD) Therapeutics estimated at US$776.4 Million in the year 2020, is projected to reach a revised size of US$1.1 Billion by 2027, growing at a CAGR of 4.7% over the period 2020-2027.

The U.S. Market is Estimated at $228.7 Million, While China is Forecast to Grow at 4.4% CAGR

The Peripheral Arterial Disease (PAD) Therapeutics market in the U.S. is estimated at US$228.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$189.1 Million by the year 2027 trailing a CAGR of 4.4% over the analysis period 2020 to 2027.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.5% and 3.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Select Competitors (Total 23 Featured):

  • AstraZeneca Plc.

  • Bayer HealthCare Pharmaceuticals

  • Bristol-Myers Squibb Company

  • Merck & Co., Inc.

  • Proteon Therapeutics, Inc.

  • Sanofi S.A.

  • Symic Bio, Inc.

  • TheraVasc, Inc.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights

  • World Market Trajectories

  • PAD - A Prelude

  • Recent Market Activity

  • PAD Statistics

  • Critical Limb Ischemia - An Insight

  • High Costs - A Cause of Concern

  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

  • Aging - A Key Driver

  • High Diabetes Incidence Worldwide: Key Market Opportunity for PAD Therapeutics

4. GLOBAL MARKET PERSPECTIVE

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/8tqgxu

View source version on businesswire.com: https://www.businesswire.com/news/home/20211207005520/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting